# Joel S. Parker

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/joel-s-parker/

## Facts

| Field | Value |
| --- | --- |
| Citations | 137,811 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 138 |
| i10-index | 338 |
| Last Known Institution | University of North Carolina at Chapel Hill |
| OpenAlex ID | https://openalex.org/A5054811851 |
| ORCID iD | https://orcid.org/0000-0003-2080-6901 |
| Works | 1,039 |

## Researcher papers

- [The Immune Landscape of Cancer](https://scholariq.org/papers/the-immune-landscape-of-cancer/)
- [Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma](https://scholariq.org/papers/comprehensive-and-integrative-genomic-characterization-of-hepatocellular/)
- [The molecular portraits of breast tumors are conserved across microarray platforms](https://scholariq.org/papers/the-molecular-portraits-of-breast-tumors-are-conserved-across-microarray/)
- [The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models](https://scholariq.org/papers/the-microarray-quality-control-maqc-ii-study-of-common-practices-for-the/)
- [Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers](https://scholariq.org/papers/androgen-receptor-signaling-regulates-dna-repair-in-prostate-cancers/)
- [Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031](https://scholariq.org/papers/randomized-phase-ii-neoadjuvant-comparison-between-letrozole-anastrozole-and/)
- [Integrated Molecular Characterization of Testicular Germ Cell Tumors](https://scholariq.org/papers/integrated-molecular-characterization-of-testicular-germ-cell-tumors/)
- [Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer](https://scholariq.org/papers/rapid-clearance-profile-of-plasma-circulating-tumor-hpv-type-16-dna-during/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

## Researcher university

- [University of North Carolina at Chapel Hill](https://scholariq.org/institutions/university-of-north-carolina-at-chapel-hill/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.